Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis

Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis

Resource Type

CF Research News

Authors

Cameron J. McKinzie, Jennifer L. Goralski, Terry L. Noah, George Z. Retsch-Bogart, Mary Beth Prieur

References

J Cyst Fibros. 2017 Jul;16(4):525-527. doi: 10.1016/j.jcf.2017.05.008. Epub 2017 Jun 8.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Date

Sunday, July 16, 2017

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [3]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/worsening-anxiety-and-depression-after-initiation

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-17-00097R2_FINAL_McKinzie_09072017.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Worsening%20anxiety%20and%20depression%20after%20initiation%20of%20lumacaftor/ivacaftor%20combination%20therapy%20in%20adolescent%20females%20with%20cystic%20fibrosis [3] https://www.ecfs.eu/resource-guideline-type/other-guidelines